NASDAQ:PTCT PTC Therapeutics - PTCT Insider Trading & Ownership Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PTC Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $48.44 -0.42 (-0.86%) (As of 03/31/2023 12:00 AM ET) Add Compare Share Share Today's Range$48.30▼$50.2050-Day Range$42.19▼$48.8652-Week Range$25.01▼$55.58Volume785,691 shsAverage Volume824,444 shsMarket Capitalization$3.58 billionP/E RatioN/ADividend YieldN/APrice Target$52.00 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability PTC Therapeutics (NASDAQ:PTCT) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.00%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)9Amount OfInsider Selling(Last 12 Months)$3.30 M PTCT Insider Buying and Selling by Quarter Get PTCT Insider Trade Alerts Want to know when executives and insiders are buying or selling PTC Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PTC Therapeutics Insider Trades History Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails3/29/2023Christine Marie UtterCAOSell4,688$47.79$224,039.5238,059 3/27/2023Christine Marie UtterCAOSell26,658$45.09$1,202,009.2238,059 3/27/2023David P SouthwellDirectorSell10,000$45.10$451,000.0010,500 3/27/2023Emily Luisa HillCFOSell7,363$45.00$331,335.0038,925 1/31/2023Christine Marie UtterCAOSell325$45.63$14,829.7538,059 1/31/2023Emily Luisa HillCFOSell575$45.63$26,237.2546,288 1/31/2023Eric PauwelsInsiderSell375$45.63$17,111.2565,537 1/31/2023Mark Elliott BouldingVPSell812$45.63$37,051.5675,378 1/31/2023Stuart Walter PeltzCEOSell2,320$45.63$105,861.60166,962 1/24/2023Emily Luisa HillCFOSell223$47.45$10,581.3546,863 1/24/2023Eric PauwelsInsiderSell359$47.45$17,034.5565,912 1/24/2023Stuart Walter PeltzCEOSell284$47.45$13,475.8055,204 1/11/2023Christine Marie UtterCAOSell417$44.36$18,498.1238,384 1/11/2023Emily Luisa HillCFOSell418$44.36$18,542.4847,086 1/11/2023Mark Elliott BouldingVPSell495$44.36$21,958.2076,190 1/11/2023Matthew B KleinCOOSell2,244$44.36$99,543.8477,856 1/11/2023Neil Gregory AlmsteadInsiderSell383$44.36$16,989.8864,579 1/11/2023Stuart Walter PeltzCEOSell1,189$44.36$52,744.04169,282 1/9/2023Christine Marie UtterCAOSell706$41.66$29,411.9639,290 1/9/2023Emily Luisa HillCFOSell758$41.66$31,578.2848,001 1/9/2023Mark Elliott BouldingVPSell835$41.66$34,786.1077,275 1/9/2023Matthew B KleinCOOSell731$41.66$30,453.4682,373 1/9/2023Neil Gregory AlmsteadInsiderSell716$41.66$29,828.5665,435 1/9/2023Stuart Walter PeltzCEOSell1,786$41.66$74,404.76171,699 10/18/2022Mark Elliott BouldingVPSell299$55.06$16,462.9461,110 9/20/2022Mark Elliott BouldingVPSell1,176$55.00$64,680.0061,110 8/9/2022Stephanie OkeyDirectorSell2,296$51.62$118,519.521,867 6/7/2022Stuart Walter PeltzCEOSell407$26.83$10,919.8138,239 4/19/2022Eric PauwelsInsiderSell822$42.52$34,951.4449,772 4/19/2022Matthew B KleinCOOSell897$42.52$38,140.4456,564 4/14/2022Stuart Walter PeltzCEOSell82$45.28$3,712.9638,646 4/13/2022Mark Elliott BouldingVPSell2,276$45.17$102,806.9261,110 4/5/2022Mark Elliott BouldingVPSell5$45.00$225.0061,110 (Data available from 1/1/2013 forward) PTCT Insider Trading Activity - Frequently Asked Questions Who is on PTC Therapeutics's Insider Roster? The list of insiders at PTC Therapeutics includes Allan Steven Jacobson, Christine Marie Utter, David P Southwell, Dawn Svoronos, Emily Luisa Hill, Eric Pauwels, Mark Elliott Boulding, Matthew B Klein, Neil Gregory Almstead, Stephanie Okey, and Stuart Walter Peltz. Learn more on insiders at PTCT. What percentage of PTC Therapeutics stock is owned by insiders? 6.00% of PTC Therapeutics stock is owned by insiders. Learn more on PTCT's insider holdings. Which PTC Therapeutics insiders have been selling company stock? The following insiders have sold PTCT shares in the last 24 months: Christine Marie Utter ($2,032,229.33), David P Southwell ($451,000.00), Dawn Svoronos ($15,286.20), Emily Luisa Hill ($785,465.25), Eric Pauwels ($135,751.15), Mark Elliott Boulding ($1,503,776.07), Matthew B Klein ($168,137.74), Neil Gregory Almstead ($78,573.80), Stephanie Okey ($184,618.52), and Stuart Walter Peltz ($368,089.75). How much insider selling is happening at PTC Therapeutics? Insiders have sold a total of 129,475 PTC Therapeutics shares in the last 24 months for a total of $5,722,927.81 sold. This page (NASDAQ:PTCT) was last updated on 4/2/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.